Evolution Summit 2026 | Sep 28-29 | Park Hyatt Aviara Resort, San Diego, CA

The Evolution Summit returns September 28-29, 2026 at Park Hyatt Aviara Resort, Golf Club & Spa, San Diego, CA, bringing together leading clinical trial executives with innovative suppliers and solution providers in an invitation-only, premium setting. Expect visionary keynotes, real-world case studies, and interactive forums aligned to the most pressing challenges in clinical operations and…

BySaurabh ChaubeyMay 26, 2026

INSIGHTS+

The US FDA New Drug Approvals in April 2026

Shots: Approval activity continued strongly into April 2026, with the US FDA authorizing two significant therapies across metabolic disease and infectious disease, reinforcing the agency’s focus on chronic disease management, long-term treatment innovation, and broader patient access. Two notable therapies achieved regulatory clearance: Eli Lilly’s Foundayo for weight loss in obese or overweight adults with weight-related conditions,…

ByDipanshu DixitMay 12, 2026

EVENTS

2026 World Pediatrics Conference | October 05-06 | Osaka, Japan

2026 World Pediatrics Conference (2026WPC) is going to be held in Osaka, Japan during October 05-06, 2026. 2026WPC will focus on the new research and give the opportunity to the doctors, pediatricians, nurses, Ph.D. fellows, and professionals to present and discuss their objective to achieve the collaborative goal, providing the neonatal care, preventing from disease,…

BySaurabh ChaubeyMay 6, 2026

NEWS

Delcath Systems Publishes Subgroup Analyses of The P-III Study on Unresectable Metastatic Uveal Melanoma Patients

Shost: Delcath Systems has reported the publication of subgroup analyses from the Phase 3 (FOCUS) study in the Journal of Cancer Research and Clinical Oncology, evaluating the efficacy and safety of the HEPZATO KIT on melphalan/hepatic delivery in pts with unresectable metastatic uveal melanoma In the subgroup analyses (n=91) of the P-III (FOCUS) Study pts,…

ByDipanshu DixitJanuary 2, 2026

THOUGHTSPOT

Trends in Biopharma: The Upsurge in Multi-Omics Analysis

Last month, we explored four key trends shaping the biopharma industry in 2025. In this follow-up, we spotlight the evolving role of multi-omics analysis—a field rapidly transforming how diseases are understood, diagnosed, and treated. In 2024, the global multi-omics market was valued at $2.72 billion and is projected to reach $9.91 billion by 2033, growing…

BySaurabh ChaubeySeptember 10, 2025

INSIGHTS+

Disease of the Month – Gaucher Disease

Shots: Gaucher disease is a rare, autosomal recessive disorder that enlarges organs like the bone marrow, liver, and spleen by depositing fats (lipids) in them In this reprise of our Disease of the Month report, we present an enlightening description of Gaucher disease with a thorough study of epidemiology, market size, disease management, potential medicines,…

ByPrince GiriAugust 28, 2024

Evolution Summit 2026 | Sep 28-29 | Park Hyatt Aviara Resort, San Diego, CA

The US FDA New Drug Approvals in April 2026

2026 World Pediatrics Conference | October 05-06 | Osaka, Japan

Delcath Systems Publishes Subgroup Analyses of The P-III Study on Unresectable Metastatic Uveal Melanoma Patients

Trends in Biopharma: The Upsurge in Multi-Omics Analysis

Disease of the Month – Gaucher Disease

Contact US

FOLLOW US